// App-Quantinova.ai

VPB0119 : Evaluation of thrombotic outcomes in patients in a large clinical enterprise following COVID-19 vaccination

Researchers

Presenter

  • B. Greene

Principal Investigators

  • L. Tefera

  • J. Bena

  • N. Mehta

  • M. Chung

  • S. Cameron

Medical Centers

  • Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • Cleveland Clinic College of Medicine, Case Western Reserve University, Cleveland, OH, United States.

  • Department of Cardiovascular Medicine, Section of Cardiac Electrophysiology, Heart, Vascular & Thoracic Institute, Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, United States

  • Depts of Ophthalmology and Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Cleveland, Ohio, United States

  • Department of Cardiovascular Medicine, Section of Cardiac Electrophysiology, Heart, Vascular & Thoracic Institute, Cleveland Clinic Foundation, Cleveland, Ohio, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Transient Ischemic Attack

  • Myocardial infarction

  • Deep vein thrombosis

  • Pulmonary embolism

  • Thrombocytopenia

  • Venous thrombosis

  • Coronavirus disease

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved